Within the myelodysplastic syndrome (MDS) work package of the European LeukemiaNet,
an Expert Panel was selected according to the framework elements of the National Institutes …

Myelodysplastic syndromes are clonal marrow stem-cell disorders, characterised by
ineffective haemopoiesis leading to blood cytopenias, and by progression to acute myeloid …

… The algorithms outline management of primary MDS only. Most patients with therapy-related
MDS have poorer prognoses than those with primary MDS, including a substantial …

… , or after treatment of a primary malignancy with alkylating agents or topoisomerase II inhibitors.
… -T; it is unlikely to be the primary event driving the myelodysplasia seen in this disorder. …

During the past 15 years, important progress has been made in the understanding of the
biology and prognosis of myelodysplastic syndrome (MDS). MDS is a clonal disorder …

… In 1982 the FAB group proposed a classification of myelodysplastic syndromes based on …
in the cytological evaluation of myelodysplastic syndromes, although controversies existed …

… To share our 25 years of experience with patients with primary myelodysplastic syndromes
(MDS) and to describe the natural history of the disease including presenting clinical and …

Myelodysplastic syndromes (MDS) are probably the most common hematologic malignancies
in adults over the age of 60 and are a major source of morbidity and mortality among older …

Forty-nine patients with primary myelodysplastic syndromes (MDS) were subclassified
according to French-American-British (FAB) Cooperative Group criteria. Eight patients had …

… in 20 patients with primary myelodysplastic syndromes (PMDS)… of patients with primary
myelodysplastic syndromes (PMDS, ‘… The myelodysplastic syndromes presumably result from the …